Expansion through AddLife Following AddLife's acquisition of Fischer Medical Technologies, there is a clear path to use AddLife's regional distribution and hospital networks to grow sales of breast imaging, biopsy and electrophysiology systems. Propose channel partnerships, joint marketing and direct business development outreach to hospitals and imaging centers in Nordic and European markets to accelerate adoption of the Bloom Stimulators and imaging platforms.

Service Upgrades Fischer Medical has an established track record with the Bloom Stimulator family and multiple imaging systems, creating a sizable installed base in need of parts, service and upgrades. Sales opportunities exist in maintenance contracts, spare parts, calibration and retrofit projects to introduce the Bloom2 stimulator and newer imaging modules to clinics.

Cross Sell Opportunities The integrated portfolio in breast imaging, biopsy and electrophysiology creates opportunities to sell bundled solutions to clinics seeking a complete breast care workflow. Target accounts with imaging platforms that can be enhanced with biopsy guidance and stimulation modules to increase deal size and stickiness.

Tech Modernization The tech stack hints at on premise systems with strong security focus. There is demand for upgrading data management and interoperability including DICOM PACS integration, secure remote monitoring and cloud based analytics. This opens a sales angle for hardware plus software services and cybersecurity enhancements.

Financing and Procurement With a mid market profile and growth through strategic acquisition, offering flexible financing and procurement support can accelerate sales to hospitals and clinics upgrading imaging and electrophysiology systems and help reach new markets through AddLife channels.